Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy’s Laboratories informs about incorporation of step down wholly-owned subsidiary

Date: 05-10-2024

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Dr. Reddy’s Laboratories has informed that Dr. Reddy’s Laboratories SA, Switzerland, (‘DRSA’) a wholly owned subsidiary of the Company, has incorporated a new wholly-owned subsidiary in Denmark, named ‘Dr. Reddy's Denmark ApS’ on October 4, 2024. Accordingly, Dr. Reddy's Denmark ApS is a step-down wholly-owned subsidiary of the Company. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, with respect to the above incorporation of a step down wholly-owned subsidiary is given in Annexure enclosed.

The above information is a part of company’s filings submitted to BSE.